GW 406381

Drug Profile

GW 406381

Alternative Names: '381; 406381; GW 406381X

Latest Information Update: 04 Apr 2013

Price : *
* Final gross price and currency may vary according to local VAT and billing address.

At a glance

  • Originator GlaxoSmithKline
  • Class Antimigraines; Antirheumatics; Aromatic hydrocarbons; Elements; Non-opioid analgesics; Pyrazoles; Pyridazines; Small molecules
  • Mechanism of Action Cyclo-oxygenase 2 inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.


Highest Development Phases

  • Discontinued Dental pain; Osteoarthritis; Pain; Rheumatoid arthritis

Most Recent Events

  • 05 May 2005 A preclinical study has been added to the Pain pharmacodynamics section
  • 23 Nov 2004 Phase-II clinical trials in Osteoarthritis (unspecified route)
  • 23 Nov 2004 Phase-II clinical trials in Rheumatoid arthritis (unspecified route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top